Metraipolis › archive › dc_2b5934998c91

Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab — Europe PMC PMID:41753180

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41753180
DOI
10.3390/jcm15041492
License (as archived)
solo-consultazione
Archived
2026-11-05T19:39:25.488Z
SHA-256 of the archived text
4f69b2a53d784901203d60568d1bd02ac909d038b5fd9c30d0f634bbb479643a
Stable URL of this page
https://metraipolis.com/documento/dc_2b5934998c91

How to cite

Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab — Europe PMC PMID:41753180 — Europe PMC (en), https://europepmc.org/article/MED/41753180 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b5934998c91 (Metraipolis archive dc_2b5934998c91, sha256 4f69b2a53d784901203d60568d1bd02ac909d038b5fd9c30d0f634bbb479643a)
BibTeX
@misc{dc2b5934998c91,
  title = {Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab — Europe PMC PMID:41753180},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41753180},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b5934998c91; sha256 4f69b2a53d784901203d60568d1bd02ac909d038b5fd9c30d0f634bbb479643a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753180. Agents can read the archived copy with the MCP tool read_document.